Repurposing TACE-induced hypoxia to activate biocatalytic hydrogen production and potentiate tirapazamine chemoimmunotherapy against hepatocellular carcinoma
Transcatheter arterial chemoembolization (TACE) is a first-line therapy for advanced hepatocellular carcinoma (HCC), however, embolization-induced tumor hypoxia frequently promotes drug resistance and recurrence. To convert this hypoxic stress into a therapeutic opportunity, we constructed hyaluronidase-degradable hyaluronic acid (HA)-based microspheres (Sp/TPZ@Ms) co-encapsulating live Synechocystis (Sp) for biohydrogen production and tirapazamine (TPZ), a hypoxia-activated prodrug. Upon embolization, the resultant hypoxic microenvironment triggers endogenous hydrogenase-mediated H₂ generation from Sp and simultaneously activates TPZ. The evolved H₂ potentiates TPZ-induced DNA damage, eliciting robust immunogenic cell death (ICD), which subsequently promotes dendritic cell maturation and M1 polarization of tumor-associated macrophages. In vitro, Sp/TPZ@Ms under hypoxia significantly enhanced HepG2 cell killing and immune activation. In a rabbit orthotopic Vx2 HCC model, the microspheres exhibited favorable injectability, embolization performance, and HAase-responsive degradation, leading to marked tumor growth suppression and reduced pulmonary metastasis with good biosafety. This cascade strategy converts hypoxic stress into a therapeutic asset, offering a novel paradigm for TACE potentiation.
Authors
- Xiangyu Lu (ORCID: https://orcid.org/0000-0002-5354-9131)
- Xiaoshuang Chen (ORCID: https://orcid.org/0000-0002-3949-2546)
- Yu He (ORCID: https://orcid.org/0009-0001-9069-9331)
- Yue Zhu (ORCID: https://orcid.org/0000-0001-7390-7082)
- Shi Zhou (ORCID: https://orcid.org/0000-0002-0096-3769)
- Renjie Liang
- Yuefeng He
- Wenhao Li
- Lei Cao
Institutions
- Guiyang Medical University (CN)
- University of Electronic Science and Technology of China (CN)
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
- Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (CN)
Publication Details
- Journal
- Journal of Nanobiotechnology
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1186/s12951-026-05285-2
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bijzonder Onderzoeksfonds UGent